I'm creating another account just for you! Learn How I Plan to Turn

$5,000 into $25,000

Phase 1: $5,000 - $25,000 (estimated time needed: 3 months)

Most new traders think you need a huge account to make money in the market, but that is completely false. I'm going to show you exactly how it's done, starting with just $5,000. Trade over my shoulder!

Phase 2: $25,000 - $200,000 (estimated time needed: 3 months)

I started this 2 months ago and have taken $25000 into over $100,000. I will keep growing this account and helping every step of the way. The $5,000 account will be another individual account. No matter the stage you're in, I've got you covered!

Phase 3: $200,000 - $1,000,000 (estimated time needed: 1 year)

This is where I'll show you how to use $200,000 to make $1,000,000+ yearly. And since I normally trade with about $200,000 in my account, you'll learn EVERY account hacking strategy I have, something I call 'trading buckets' to make $1,000,000+ each year

Trading stocks is inherently risky. There is no guarantee you will make money or replicate Kyle's performance nor that Kyle will be able to replicate past results.

How to Join Me

  1. Only for BiotechBreakouts.com Nucleus subscribers
  2. Phase I starts January 2nd, 2018.
  3. Phase II has begun. I've turned $25,000 into over $100,000 so far. Everything is being recorded.
  4. If you have a small account, you need to be in here before the new year starts. I'm taking $5,000 to $25,000 and want you to do it with me!

| save 70% with promocode: xmas70

SAVE 70% NOW! Deal ends in:

We closed up the registration for The Heist training session, but I was able to open 25 extra seats!

RESERVE YOUR SEAT HERE

First come first serve. Be sure to act fast!


 

I booked a nice profit on SNGX today, as it spiked up on news of a patent. I’ll be looking to buy back into this company sometime likely within the next couple weeks. I also sold BLRX and will be likely buying that one back sometime in September. It was just a really slow mover and my money is served better in a more active stock.

 

I added to my position in CKPT, which closed up higher and finished near the high of the day. The chart looks primed for a continuation to my targets soon.

I am also still holding SELBADMAVKTX and VSTM in the portfolio as well.

 

Reminder: Charts are updated every Sunday evening for the next week!

 

Catalyst Swing Names (1-4 week holds) that I am watching

 

Checkpoint Therapeutics (CKPT)

 

Catalyst Dates: Phase 1/2 late breaking data due out September 24th

Buy Zone: $3.55 to $3.95

Profit Zone: $4.50 or higher

Stop Zone: $3.30 or below

 

BioLineRX (BLRX)

Catalyst Dates: Phase 2 topline results due out October 19th

Buy Zone: $.87 to $.92

Profit Zone: $1.00 or higher

Stop Zone: $.85 or below

 

Soligenix (SNGX)

Catalyst Dates: Phase 3 interim analysis due out in October 2018.

Buy Zone: $1.35 to $1.55

Profit Zone: $1.80 or higher

Stop Zone: $1.15 or below

 

Mirati Therapeutics (MRTX)

Catalyst Dates: Phase 1 and Phase 2 data due out October 21 and 22.

Buy Zone: $55.00 to $58.00

Profit Zone: $65.00 or higher

Stop Zone: $50.50 or below

 

Adma Biologics (ADMA)

Catalyst Dates: FDA Approval date of October 25th 2018.

Buy Zone: $5.50 to $5.80

Profit Zone: $6.25 or higher

Stop Zone: $5.30 or below

 

AcelRx (ACRX)

Catalyst Dates: FDA Approval date of November 3, likely to have an 
Advisory Committee meeting announce beforehand.

Buy Zone: $2.60 to $2.90

Profit Zone: $3.40 or higher

Stop Zone: $2.50 or below

 

Verastem (VSTM)

Catalyst Dates: FDA approval date of October 5th. Earnings should be August 8th.

Buy Zone: $7.75 to $8.15

Profit Zone: $9.00 or higher

Stop Zone: $7.00 or below

 

Viking Therapeutics (VKTX)

Catalyst Dates: Phase 2 data due September 30th. Another Phase 2 data set due out likely in late 2018.

Buy Zone: $9.75 to $10.35

Profit Zone: $12.00 or higher

Stop Zone: $9.40 or below

 

Selecta Biosciences (SELB)

 

Catalyst Dates:  Phase 2 data due out in October

Buy Zone: $12.00 to $13.00

Profit Zone: $16.00 or higher

Stop Zone: $11.50 or below

 

Trevena (TRVN)

 

Catalyst Dates: FDA Approval date of November 2, likely to have an 
Advisory Committee meeting announce beforehand

Buy Zone: $1.40 to $1.60

Profit Zone: $2.10 or higher

Stop Zone: $1.30 or below

I’ll be in touch again soon!